As per the new research report by RNCOS, “US Non-Invasive Prenatal Diagnostics - Market Insight” the market for non-invasive prenatal diagnostics in US is expanding at a rapid rate. This growth can be attributed to several factors, foremost of all being its high acceptance amongst high-risk pregnant mothers. NIPD tests available in the US market completely eliminate the risk associated with invasive prenatal tests like CVS and Amniocentesis, gaining them instant popularity amongst the consumers. Another factor significantly boosting the market is the low involvement of FDA in the launch of these tests. All non-invasive prenatal tests in market are laboratory-developed tests that are not subject to US FDA regulations. This has resulted in shortened launch time, propelling the growth of the market.
In a year’s span, the market has witnessed the entry of four players; Sequenom, Verinata, Ariosa diagnostics and Natera - being the latest entrant. Almost all the players have now formed tie-ups with major insurance providers and are ensuring that their products are reimbursed. Research and innovation in the sector is robust and there are several clinical trials being done to further validate service offerings. These factors have made the tests popular amongst the healthcare providers who are now increasingly recommending NIPD test for screening purposes. Backed by such factors, the US NIPD market is expected to grow at a high CAGR of around 49% during 2012-2017. The sector has a highly untapped potential and is expected to evolve greatly in the future.
The report provides an in-depth research and rational analysis of the current status and expected position of the US NIPD Market by 2017. Moreover, opportunity assessment for companies in the US NIPD Market in terms of leading technologies is also analyzed in the report. In addition, the report elaborates on the various restraints faced by the sector. To provide a holistic view, it also provides a competitive assessment of the major players describing their key business and comparing their strengths and weaknesses.
For FREE SAMPLE of this report visit: http://www.rncos.com/Report/IM450.htm
Some of our Related Reports are:
- Global Insulin Delivery Devices Market Forecast to 2017 (http://www.rncos.com/Report/IM494.htm)
- Genetic Testing Market Outlook to 2017 (http://www.rncos.com/Report/IM492.htm)
- Analysis of Coronary Stent in US (http://www.rncos.com/Report/IM489.htm)
- US Healthcare IT Market Outlook to 2017 (http://www.rncos.com/Report/IM487.htm)
- US Personalized Cancer Genome Sequencing Market (http://www.rncos.com/Report/IM453.htm)
Check Related REPORTS on: http://www.rncos.com/Healthcare_Industry.htm
RNCOS specializes in Industry intelligence and creative solutions for contemporary business segments. Our professionals analyze the industry and its various components, with a comprehensive study of the changing market behavior. Our accuracy and data precision proves beneficial in terms of pricing and time management that assist the intending consultants in meeting their objectives in a cost-effective and timely manner.